Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How the coronavirus infects cells — and why Delta is so dangerous
Megan Scudellari
Nature (2021) Vol. 595, Iss. 7869, pp. 640-644
Closed Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
Saathvik R. Kannan, Austin N. Spratt, Alisha R. Cohen, et al.
Journal of Autoimmunity (2021) Vol. 124, pp. 102715-102715
Open Access | Times Cited: 258
Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals
Chun Huai Luo, C. Paul Morris, Jaiprasath Sachithanandham, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e715-e725
Open Access | Times Cited: 140
Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals
Chun Huai Luo, C. Paul Morris, Jaiprasath Sachithanandham, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 134
Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants
Anshumali Mittal, Arun Khattri, Vikash Verma
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010260-e1010260
Open Access | Times Cited: 115
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern
Hikmet Akkız
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 82
A spatiotemporally resolved infection risk model for airborne transmission of COVID-19 variants in indoor spaces
Xiangdong Li, Daniel Lester, Gary Rosengarten, et al.
The Science of The Total Environment (2021) Vol. 812, pp. 152592-152592
Open Access | Times Cited: 58
Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure–Activity Relationships, Antiviral Activity, and X-ray Structure Determination
Thanigaimalai Pillaiyar, Philipp Flury, Nadine Krüger, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 9376-9395
Closed Access | Times Cited: 55
Human coronaviruses: Origin, host and receptor
Guolu Tang, Zhenwei Liu, Dehui Chen
Journal of Clinical Virology (2022) Vol. 155, pp. 105246-105246
Open Access | Times Cited: 51
Will the COVID-19 pandemic end with the Delta and Omicron variants?
Chaoqi Wang, Jie Han
Environmental Chemistry Letters (2022) Vol. 20, Iss. 4, pp. 2215-2225
Open Access | Times Cited: 48
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 43
Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives
Tao Dong, Mingyang Wang, Junchong Liu, et al.
Chemical Science (2023) Vol. 14, Iss. 23, pp. 6149-6206
Open Access | Times Cited: 35
Early mutational signatures and transmissibility of SARS-CoV-2 Gamma and Lambda variants in Chile
Karen Oróstica, Sebastian Mohr, Jonas Dehning, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy
Abdulhamid Abdi, Shahad AlOtaiby, Firas Al Badarin, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112518-112518
Open Access | Times Cited: 41
Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection
He Ren, Chaobing Ma, Haoran Peng, et al.
Biology Direct (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 40
Identification of SARS-CoV-2 Spike Palmitoylation Inhibitors That Results in Release of Attenuated Virus with Reduced Infectivity
Ahmed Ramadan, Karthick Mayilsamy, Andrew R. McGill, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 531-531
Open Access | Times Cited: 36
Spike protein of SARS-CoV-2 variants: a brief review and practical implications
Kattlyn Laryssa Candido, Caio Ricardo Eich, Luciana Oliveira de Fariña, et al.
Brazilian Journal of Microbiology (2022) Vol. 53, Iss. 3, pp. 1133-1157
Open Access | Times Cited: 34
Approaches and materials for endocytosis-independent intracellular delivery of proteins
Nanxi Chen, Ye He, Mingming Zang, et al.
Biomaterials (2022) Vol. 286, pp. 121567-121567
Open Access | Times Cited: 33
Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis
Karim M. Aloul, Josefine Eilsø Nielsen, Erwin B. Defensor, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Aprotinin treatment against SARS‐CoV‐2: A randomized phase III study to evaluate the safety and efficacy of a pan‐protease inhibitor for moderate COVID‐19
Francisco Javier Redondo Calvo, Juan Fernando Padín, José Ramón Muñoz‐Rodríguez, et al.
European Journal of Clinical Investigation (2022) Vol. 52, Iss. 6
Open Access | Times Cited: 29
In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools
Anish Nag, Subhabrata Paul, Ritesh Banerjee, et al.
Computers in Biology and Medicine (2021) Vol. 137, pp. 104818-104818
Open Access | Times Cited: 39
Screening S protein – ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19
Le-le Ma, Huimin Liu, Xuemei Liu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113857-113857
Open Access | Times Cited: 33
Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19
Jianwei Zhang, Yuan Xiong, Feng Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 114030-114030
Open Access | Times Cited: 32
Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
Weiqi Yao, Lei Shi, Yun Zhang, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Microfluidic affinity selection of active SARS-CoV-2 virus particles
Sachindra S. T. Gamage, Thilanga N. Pahattuge, Harshani Wijerathne, et al.
Science Advances (2022) Vol. 8, Iss. 39
Open Access | Times Cited: 22
Integrating Fréchet distance and AI reveals the evolutionary trajectory and origin of SARS‐CoV‐2
Anyou Wang
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top